AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28043055 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining
Number of subjects: 29
Study 28043055 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 29
Study 26682747 — intervention group
Group type: EXPERIMENTAL
Intervention: GH(67) 67 μg/kg/day (once daily)
Number of subjects: 104
Study 26682747 — intervention group
Group type: COMPARATOR
Intervention: GH(33) 33 μg/kg/day (once daily)
Number of subjects: 104
Study 26682747 — intervention group
Group type: EXPERIMENTAL
Intervention: GH(33x2) 33 μg/kg/day (divided into two daily injections)
Number of subjects: 104
Study 22688433 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based navigation
Number of subjects: 0
Study 22688433 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy
Number of subjects: 0
Study 22688433 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer navigation at transfer test
Number of subjects: 0
Study 21575292 — intervention group
Group type: EXPERIMENTAL
Intervention: 2EHRZ/6HE regimen (daily EMB, INH, RMP, and PZA for 2 months, followed by EMB+INH for 6 months)
Number of subjects: 1355
Study 21575292 — intervention group
Group type: EXPERIMENTAL
Intervention: 2(EHRZ)(3)/6HE regimen (same drugs in the intensive phase but given three times weekly, followed by daily EMB+INH for 6 months)
Number of subjects: 1355
Study 21575292 — intervention group
Group type: COMPARATOR
Intervention: 2EHRZ/4HR regimen (same intensive phase as in regimen 1, followed by 4 months of daily RMP+INH)
Number of subjects: 1355
Study 18291010 — intervention group
Group type: EXPERIMENTAL
Intervention: Care sought outside the home
Number of subjects: 2878
Study 18291010 — intervention group
Group type: EXPERIMENTAL
Intervention: Care sought from a doctor or hospital
Number of subjects: 2878
Study 18291010 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional medicine as first-line treatment
Number of subjects: 2878
Study 18291010 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to care seeking
Number of subjects: 2878
Study 16784035 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel technique using jejunal serosa for pancreatic stump closure (n=23)
Number of subjects: 50
Study 16784035 — intervention group
Group type: COMPARATOR
Intervention: Traditional method using stapler and handsewn suturing (n=27)
Number of subjects: 50
Study 14505898 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa vaccine
Number of subjects: 330
Study 14505898 — intervention group
Group type: COMPARATOR
Intervention: DTPw vaccine
Number of subjects: 330
Study 11022777 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD), 20 mg bid
Number of subjects: 76
Study 11022777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 8774026 — intervention group
Group type: EXPERIMENTAL
Intervention: CardioGlide
Number of subjects: 67
Study 8774026 — intervention group
Group type: EXPERIMENTAL
Intervention: CrossWalk
Number of subjects: 67
Study 8774026 — intervention group
Group type: EXPERIMENTAL
Intervention: treadmill
Number of subjects: 67
Study 1611143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (10 mg/kg/day, single daily dose)
Number of subjects: 23
Study 1611143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 6322987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin, and cisplatin
Number of subjects: 106
Study 6322987 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate, doxorubicin, cyclophosphamide, and lomustine
Number of subjects: 106
Study 31623621 — intervention group
Group type: EXPERIMENTAL
Intervention: Firocoxib
Number of subjects: 79
Study 31623621 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSO-524
Number of subjects: 79
Study 31623621 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of firocoxib and PCSO-524
Number of subjects: 79
Study 31623621 — intervention group
Group type: COMPARATOR
Intervention: Control (PCSO-524)
Number of subjects: 79
Study 29546306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubaramure program (T24) - food rations for the first 1000 days, BCC
Number of subjects: 3550
Study 29546306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubaramure program (T18) - food rations from pregnancy through 18 months, BCC
Number of subjects: 3550
Study 29546306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubaramure program (TNFP) - no food during pregnancy, food rations from birth through 24 months, BCC
Number of subjects: 3550
Study 29546306 — intervention group
Group type: COMPARATOR
Intervention: Control group - no food rations or BCC
Number of subjects: 3550
Study 26654115 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT-S (Culturally Informed Therapy)
Number of subjects: 113
Study 26654115 — intervention group
Group type: COMPARATOR
Intervention: PSY-ED (Psychoeducation)
Number of subjects: 113
Study 25626655 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZ) 500mg/day for 20 days
Number of subjects: 24
Study 25626655 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate (MA) 15mg/kg/day up to 1,215mg for 20 days
Number of subjects: 24
Study 22571902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose peginterferon-alfa-2a (PEG-IFN)
Number of subjects: 186
Study 22571902 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 186
Study 19799627 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyurea and l-carnitine
Number of subjects: 120
Study 19799627 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyurea and magnesium chloride
Number of subjects: 120
Study 19799627 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyurea, l-carnitine and magnesium chloride
Number of subjects: 120
Study 19799627 — intervention group
Group type: COMPARATOR
Intervention: hydroxyurea alone
Number of subjects: 120
Study 17662787 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 30
Study 17662787 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel
Number of subjects: 30
Study 17662787 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 30
Study 17662787 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative
Number of subjects: 30
Study 16261883 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrase 15 U plus normal saline 250 mL, followed by defibrase 5 U on days 3, 5, 7, and 9
Number of subjects: 1053
Study 16261883 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrase
Number of subjects: 1053
Study 11999913 — intervention group
Group type: EXPERIMENTAL
Intervention: RHYTHMS adherence enhancement program
Number of subjects: 0
Study 11999913 — intervention group
Group type: COMPARATOR
Intervention: Sertraline treatment
Number of subjects: 0
Study 9617677 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic bone implants (ABI)
Number of subjects: 52
Study 9617677 — intervention group
Group type: COMPARATOR
Intervention: Adsorbable gelatine sponge
Number of subjects: 52
Study 7656888 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amylose starch in starchy drinks and puddings
Number of subjects: 49
Study 7656888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat addition to starchy drinks, puddings, and rolls
Number of subjects: 49
Study 7656888 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum addition to rolls
Number of subjects: 49
Study 7656888 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental foods as mid-morning snack
Number of subjects: 49
Study 2699572 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-tufted short-head toothbrushes with different bristle bed designs
Number of subjects: 15
Study 2699572 — intervention group
Group type: EXPERIMENTAL
Intervention: Slanted bristle bed toothbrush
Number of subjects: 15
Study 9689 — intervention group
Group type: EXPERIMENTAL
Intervention: epicillin
Number of subjects: 96
Study 9689 — intervention group
Group type: EXPERIMENTAL
Intervention: ampicillin
Number of subjects: 96
Study 7361102 — intervention group
Group type: EXPERIMENTAL
Intervention: Food dye blend (100 or 150 milligrams)
Number of subjects: 40
Study 7361102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31779603 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person training model
Number of subjects: 53
Study 31779603 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training model
Number of subjects: 53
Study 31779603 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 28703950 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based psychoeducation treatment group (n = 40)
Number of subjects: 80
Study 28703950 — intervention group
Group type: COMPARATOR
Intervention: Internet-based control group with no psychoeducation (n = 40)
Number of subjects: 80
Study 28186932 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised 1:1 physiotherapy outpatient intervention including education, advice, mobility and core stability exercises, progressive exercise, and encouragement of early return to work/activity (≤8 sessions for ≤8 weeks, starting 4 weeks post surgery)
Number of subjects: 29
Study 25114907 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-channel FES
Number of subjects: 45
Study 25114907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 25114907 — intervention group
Group type: COMPARATOR
Intervention: Dual-channel
Number of subjects: 45
Study 23348488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 135
Study 23348488 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (without ultrasound)
Number of subjects: 135
Study 19346328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine agonists
Number of subjects: 0
Study 19346328 — intervention group
Group type: COMPARATOR
Intervention: Control patients (without pathological gambling)
Number of subjects: 0
Study 17488455 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 40
Study 17488455 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC)
Number of subjects: 40
Study 15249317 — intervention group
Group type: EXPERIMENTAL
Intervention: Home based strength training with loads of 50‐70% of repetition maximum (EG)
Number of subjects: 70
Study 15249317 — intervention group
Group type: COMPARATOR
Intervention: Range of motion exercises (CG)
Number of subjects: 70
Study 15249317 — intervention group
Group type: EXPERIMENTAL
Intervention: Home based strength training (EG)
Number of subjects: 70
Study 12586138 — intervention group
Group type: EXPERIMENTAL
Intervention: Lepirudin
Number of subjects: 44
Study 12586138 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 44
Study 12586138 — intervention group
Group type: EXPERIMENTAL
Intervention: CCP-aPTT
Number of subjects: 44
Study 12586138 — intervention group
Group type: EXPERIMENTAL
Intervention: STA-aPTT
Number of subjects: 44
Study 9723435 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin (RAPA)
Number of subjects: 250
Study 8077371 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH at 3-h frequency (slow)
Number of subjects: 8
Study 8077371 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH every 45 min (fast)
Number of subjects: 8
Study 2687586 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pilocarpine
Number of subjects: 0
Study 778345 — intervention group
Group type: EXPERIMENTAL
Intervention: Chymopapain
Number of subjects: 48
Study 778345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31169571 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tendon reconstruction
Number of subjects: 330
Study 31169571 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring tendon reconstruction
Number of subjects: 330
Study 31169571 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle hamstring reconstruction
Number of subjects: 330
Study 28430015 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance group therapy
Number of subjects: 117
Study 28430015 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 117
Study 25883989 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-irradiated BCG vaccination
Number of subjects: 20
Study 25883989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 23521115 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Practice Nurse Psychiatric Bridging Intervention
Number of subjects: 57
Study 23521115 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 57
Study 21219596 — intervention group
Group type: EXPERIMENTAL
Intervention: RTMM including SMS reminders and personal webpage access
Number of subjects: 0
Study 21219596 — intervention group
Group type: EXPERIMENTAL
Intervention: RTMM without SMS reminders or webpage access
Number of subjects: 0
Study 21219596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 19577160 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Virtual Object (LVO) for teaching radiographic cephalometry
Number of subjects: 40
Study 19577160 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching method (theory and practical classes)
Number of subjects: 40
Study 17049236 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking towards a goal without restrictions
Number of subjects: 0
Study 17049236 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking towards a goal with restrictions
Number of subjects: 0
Study 15138428 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (active drug)
Number of subjects: 40
Study 15138428 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study 10623692 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 156
Study 10623692 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim or sequential regimen
Number of subjects: 156
Study 10623692 — intervention group
Group type: COMPARATOR
Intervention: Sargramostim
Number of subjects: 156
Study 9369134 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanidazole (Eta) with dose and schedule adjustment
Number of subjects: 521
Study 9369134 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiation therapy (RT) alone
Number of subjects: 521
Study 1550277 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandatory drinkers (n=464)
Number of subjects: 989
Study 1550277 — intervention group
Group type: COMPARATOR
Intervention: Elective drinkers (n=525)
Number of subjects: 989
Study 2412042 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg b.i.d.)
Number of subjects: 10
Study 2412042 — intervention group
Group type: COMPARATOR
Intervention: Beta‐adrenergic blockers alone
Number of subjects: 10
Study 31019383 — intervention group
Group type: EXPERIMENTAL
Intervention: VisualDx (intervention group)
Number of subjects: 433
Study 31019383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VisualDx)
Number of subjects: 433
Study 28065677 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated diabetes care program (DIAPREM) with quarterly clinical appointments
Number of subjects: 300
Study 28065677 — intervention group
Group type: COMPARATOR
Intervention: Traditional care (Control group)
Number of subjects: 300
Study 26214725 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 50 mg twice a day
Number of subjects: 38
Study 26214725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 24114221 — intervention group
Group type: EXPERIMENTAL
Intervention: Training reinforcement group (n = 42)
Number of subjects: 124
Study 24114221 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence and training reinforcement group (n = 43)
Number of subjects: 124
Study 24114221 — intervention group
Group type: COMPARATOR
Intervention: No-reinforcement group (n = 39)
Number of subjects: 124
Study 20850275 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine up to 24mg/day
Number of subjects: 32
Study 18487480 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg daily
Number of subjects: 74
Study 18487480 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 200 mg daily
Number of subjects: 74
Study 18487480 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg plus CoQ 200 mg daily
Number of subjects: 74
Study 18487480 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 74
Study 16582861 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined transoral odontoidectomy and occipito-cervical fusion
Number of subjects: 19
Study 14768777 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-specific, high-volume, low-intensity exercise training program (NET)
Number of subjects: 90
Study 14768777 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised, low-volume and high-intensity exercise training program (IET)
Number of subjects: 90
Study 10697397 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell factor (SCF)
Number of subjects: 34
Study 10697397 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA 21.1
Number of subjects: 34
Study 10697397 — intervention group
Group type: EXPERIMENTAL
Intervention: Carcinoembryonic antigen (CEA)
Number of subjects: 34
Study 8931744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytarabine 500 mg/m2 0 h and 12 h, cisplatin 15 mg/m2 6 h and 18 h. Day 2‐4: cisplatin 30 mg/m2. Cycles repeated every 4 weeks
Number of subjects: 37
Study 1880233 — intervention group
Group type: EXPERIMENTAL
Intervention: Estazolam 2 mg
Number of subjects: 223
Study 1880233 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 223
Study 1880233 — intervention group
Group type: EXPERIMENTAL
Intervention: Estazolam 1 mg
Number of subjects: 223
Study 1880233 — intervention group
Group type: EXPERIMENTAL
Intervention: Estazolam 2 mg and Flurazepam 30 mg
Number of subjects: 223
Study 1880233 — intervention group
Group type: COMPARATOR
Intervention: Flurazepam
Number of subjects: 223
Study 1880233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 7068093 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of chlorhexidine, tramazoline and aluminiumtrilactate (n = 50)
Number of subjects: 100
Study 7068093 — intervention group
Group type: COMPARATOR
Intervention: Hexetidine (n = 49)
Number of subjects: 100
Study 31173464 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound treatment
Number of subjects: 25
Study 31173464 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 25
Study 31470879 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy (450 mL of whole blood venesection)
Number of subjects: 64
Study 31470879 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptives (OCs) containing cyproterone acetate (3 months treatment)
Number of subjects: 64
Study 27842470 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (delivered by social workers without previous mental health experience, including cognitive-behavioral therapy or facilitated antidepressant medication)
Number of subjects: 400
Study 27842470 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 400
Study 27842470 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (pamphlet about depression, letter for primary care provider, list of local mental health resources)
Number of subjects: 400
Study 25985960 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) provided by a nurse containing information on adverse events, tumor response, and survival.
Number of subjects: 77
Study 25985960 — intervention group
Group type: COMPARATOR
Intervention: Oncologists' judgment of patients' information desire.
Number of subjects: 77
Study 24130097 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer screening brochure for AA men + partner brochure with strategies
Number of subjects: 231
Study 24130097 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner brochure
Number of subjects: 231
Study 24130097 — intervention group
Group type: COMPARATOR
Intervention: Centers for Disease Control brochure only
Number of subjects: 231
Study 21742514 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric supplementation (500 mg turmeric, 22.1 mg curcumin, 3 capsules daily for 3 months)
Number of subjects: 24
Study 21742514 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (starch, identical in color and size to turmeric capsules, 3 capsules daily for 3 months)
Number of subjects: 24
Study 19631845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy procedures
Number of subjects: 0
Study 17492905 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive interventions
Number of subjects: 0
Study 17492905 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment interventions
Number of subjects: 0
Study 17492905 — intervention group
Group type: COMPARATOR
Intervention: Preventive and therapeutic studies
Number of subjects: 0
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in normal adults
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int,na) measured in normal adults
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in children
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in COPD patients
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int) measured at fixed inspiratory flows
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int) measured at flows <0.3 l s(‐1)
Number of subjects: 45
Study 15798291 — intervention group
Group type: EXPERIMENTAL
Intervention: R(int) measured at increasing flows
Number of subjects: 45
Study 12939120 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan formulation (2100 mg chitosan and 300 mg psyllium husk seeds, six capsules three times daily for three days)
Number of subjects: 29
Study 12939120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 9583342 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparing for the Drug‐Free Years Program (PDFY)
Number of subjects: 523
Study 9583342 — intervention group
Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 523